Aβ and tau structure‐based biomarkers for a blood‐ and CSF‐based two‐step recruitment strategy to identify patients with dementia due to Alzheimer's disease
Abstract Introduction Alzheimer's disease (AD) diagnosis requires invasive CSF analysis or expensive brain imaging. Therefore, a minimal‐invasive reliable and cost‐effective blood test is requested to power large clinical AD trials at reduced screening failure. Methods We applied an immuno‐infrared...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2019-12-01
|
| coleção: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1016/j.dadm.2019.01.008 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|